We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
(+4.3%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$190M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$171M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$139M |
| 4 |
Textron
TXT
|
+$133M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$325M |
| 2 |
EOG Resources
EOG
|
+$245M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Merck
MRK
|
+$149M |
| 5 |
Kohl's
KSS
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Regal Rexnord
RRX
$14.5B
| $28.2M | 0.06% |
210,857
+154,857
| +277% | +$21.9M |
|
352
Amalgamated Financial
AMAL
$1.5B
| $28.1M | 0.06% |
1,800,000
+34,493
| +2% | +$559K |
|
353
Kraft Heinz
KHC
$31.4B
| $28.1M | 0.06% |
689,032
-16,900
| -2% | -$711K |
|
354
Progressive
PGR
$122B
| $28M | 0.05% |
284,985
-230,300
| -45% | -$22.8M |
|
355
Sarepta Therapeutics
SRPT
$1.71B
| $28M | 0.05% |
+359,753
| New | +$27.3M |
|
356
Generac Holdings
GNRC
$12.9B
| $28M | 0.05% |
+67,358
| New | +$22.6M |
|
357
Bunge Global
BG
$20.7B
| $27.8M | 0.05% |
355,242
-670,000
| -65% | -$56.6M |
|
358
Hershey
HSY
$35.8B
| $27.6M | 0.05% |
158,685
-3,800
| -2% | -$640K |
|
|
RONI.U
359
DELISTED
Rice Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RONI.U
| $27.6M | 0.05% |
+2,700,000
| New | +$27.5M |
|
360
LyondellBasell Industries
LYB
$19.6B
| $27.5M | 0.05% |
267,700
+43,300
| +19% | +$4.69M |
|
|
ZTAQU
361
DELISTED
Zimmer Energy Transition Acquisition Corp. Units
ZTAQU
| $27.4M | 0.05% |
+2,700,000
| New | +$27.3M |
|
|
PDOT
362
DELISTED
Peridot Acquisition Corp. II
PDOT
| $27.3M | 0.05% |
+2,800,000
| New | +$27.3M |
|
363
Viavi Solutions
VIAV
$10.2B
| $27.3M | 0.05% |
1,543,721
-170,000
| -10% | -$2.87M |
|
|
BHIL
364
DELISTED
Benson Hill, Inc.
BHIL
| $27.2M | 0.05% |
78,543
-28
| -0% | -$9.82K |
|
|
VERV
365
DELISTED
Verve Therapeutics
VERV
| $27.2M | 0.05% |
+451,680
| New | +$18.7M |
|
366
Alexandria Real Estate Equities
ARE
$8.71B
| $27.2M | 0.05% |
149,400
+7,800
| +6% | +$1.4M |
|
367
Enphase Energy
ENPH
$5.52B
| $27.1M | 0.05% |
147,500
+3,700
| +3% | +$543K |
|
368
CDW
CDW
$19.2B
| $27M | 0.05% |
154,800
-8,700
| -5% | -$1.5M |
|
369
Oneok
OKE
$54.9B
| $26.9M | 0.05% |
483,000
+24,600
| +5% | +$1.31M |
|
370
PACCAR
PCAR
$71.4B
| $26.5M | 0.05% |
445,199
-130,767
| -23% | -$8.02M |
|
371
Keysight
KEYS
$58.5B
| $26.2M | 0.05% |
169,674
-13,738
| -7% | -$1.99M |
|
372
Cabaletta Bio
CABA
$452M
| $26.2M | 0.05% |
3,041,645
| – | – |
|
|
CERN
373
DELISTED
Cerner Corp
CERN
| $26.2M | 0.05% |
334,620
+117,100
| +54% | +$9.01M |
|
374
C4 Therapeutics
CCCC
$400M
| $26.1M | 0.05% |
690,000
-190,498
| -22% | -$6.82M |
|
|
PFPT
375
DELISTED
Proofpoint, Inc.
PFPT
| $26.1M | 0.05% |
+150,000
| New | +$24.3M |
|
Similar funds
Adage Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
- Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
- Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
- Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
- Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
- Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
- Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.